Prognostication for oral squamous cell carcinoma patients based on the tumour–stroma ratio and tumour budding

Autor: Dourado, M. R. (Maurício R), Miwa, K. Y. (Karen Y M), Hamada, G. B. (Guilherme B), Paranaíba, L. M. (Lívia M R), Sawazaki‐Calone, Í. (Íris), Domingueti, C. B. (Catherine B), Ervolino de Oliveira, C. (Carine), Furlan, E. C. (Emylle C B), Longo, B. C. (Bruna C), Almangush, A. (Alhadi), Salo, T. (Tuula), Coletta, R. D. (Ricardo D)

Aims: Previous studies have demonstrated that the tumour–stroma ratio (TSR) and tumour budding are of prognostic value for oral squamous cell carcinomas (OSCCs). The aim of this study was to evaluate the prognostic significance of those histologica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2423::175948426f166e676266e206b10ed2b7
http://urn.fi/urn:nbn:fi-fe2020061042616

Extracellular vesicles from oral squamous carcinoma cells display pro- and antiangiogenic properties

Autor: Dias Leite de Andrade, A. L. (Ana Luiza), Ervolino de Oliveira, C. (Carine), Rocha Dourado, M. (Maurício), Carneiro Soares Macedo, C. (Carolina), Vischi Winck, F. (Flávia), Franco Paes Leme, A. (Adriana), Salo, T. (Tuula), Coletta, R. D. (Ricardo D.), de Almeida Freitas, R. (Roseana), Cavalcanti Galvão, H. (Hébel)

Background: A new intercellular communication mode established by neoplastic cells and tumor microenvironment components is based on extracellular vesicles (EVs). However, the biological effects of the EVs released by tumor cells on angiogenesis are

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2423::fe4533982f3123771b4c4d9a60e04f3e
http://urn.fi/urn:nbn:fi-fe2017113055178

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Fascin promotes migration and invasion and is a prognostic marker for oral squamous cell carcinoma.

Autor: Rodrigues PC; Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba, SP, Brazil.; Unit of Cancer Research and Translational Medicine, Faculty of Medicine and Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland., Sawazaki-Calone I; Oral Pathology and Oral Medicine, Dentistry School, Western Paraná State University, Cascavel, PR, Brazil., Ervolino de Oliveira C; Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba, SP, Brazil., Soares Macedo CC; Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba, SP, Brazil., Dourado MR; Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba, SP, Brazil.; Unit of Cancer Research and Translational Medicine, Faculty of Medicine and Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland., Cervigne NK; Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba, SP, Brazil.; Current/Present address: Clinical Department, Faculty of Medicine of Jundiai, Jundiai, SP, Brazil., Miguel MC; Department of Dentistry, Federal University of Rio Grande do Norte, Natal, RN, Brazil., Ferreira do Carmo A; Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba, SP, Brazil.; Department of Dentistry, Federal University of Rio Grande do Norte, Natal, RN, Brazil., Lambert DW; Integrated Biosciences, School of Clinical Dentistry and Sheffield Cancer Centre, University of Sheffield, Sheffield, United Kingdom., Graner E; Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba, SP, Brazil., Daniela da Silva S; Departments of Medicine, Oncology, Pharmacology and Therapeutics, Segal Cancer Centre and Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec, Canada.; Otolaryngology-Head and Neck Surgery, Faculty of Medicine, McGill University, Montreal, Quebec, Canada., Alaoui-Jamali MA; Departments of Medicine, Oncology, Pharmacology and Therapeutics, Segal Cancer Centre and Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec, Canada.; Otolaryngology-Head and Neck Surgery, Faculty of Medicine, McGill University, Montreal, Quebec, Canada., Paes Leme AF; Brazilian Biosciences National Laboratory-CNPEM, Campinas, SP, Brazil., Salo TA; Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba, SP, Brazil.; Unit of Cancer Research and Translational Medicine, Faculty of Medicine and Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.; Institute of Oral and Maxillofacial Disease, University of Helsinki, and HUSLAB, Department of Pathology, Helsinki University Hospital, Helsinki, Finland., Coletta RD; Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba, SP, Brazil.

Publikováno v: Oncotarget [Oncotarget] 2017 Aug 19; Vol. 8 (43), pp. 74736-74754. Date of Electronic Publication: 2017 Aug 19 (Print Publication: 2017).